Concourse Financial Group Securities’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3
Closed -$540 2396
2024
Q2
$428 Hold
3
﹤0.01% 2212
2024
Q1
$469 Hold
3
﹤0.01% 2218
2023
Q4
$541 Hold
3
﹤0.01% 2176
2023
Q3
$539 Hold
3
﹤0.01% 2167
2023
Q2
$534 Buy
+3
New +$691 ﹤0.01% 2223
2023
Q1
Sell
-5
Closed -$1.2K 2453
2022
Q4
$1.1K Hold
5
﹤0.01% 2154
2022
Q3
$1K Sell
5
-3
-38% -$515 ﹤0.01% 1950
2022
Q2
$1K Sell
8
-1
-11% -$156 ﹤0.01% 2160
2022
Q1
$2K Buy
9
+5
+125% +$1.06K ﹤0.01% 2066
2021
Q4
$1K Buy
4
+2
+100% +$675 ﹤0.01% 2337
2021
Q3
$1K Hold
2
﹤0.01% 2367
2021
Q2
$1K Hold
2
﹤0.01% 2328
2021
Q1
$1K Buy
+2
New +$662 ﹤0.01% 2299
2020
Q4
Sell
-16
Closed -$4.41K 2374
2020
Q3
$5K Buy
16
+5
+45% +$1.18K ﹤0.01% 1821
2020
Q2
$2K Hold
11
﹤0.01% 1948
2020
Q1
$1K Hold
11
﹤0.01% 2118
2019
Q4
$2K Buy
+11
New +$1.83K ﹤0.01% 1941
2019
Q3
Sell
-11
Closed -$1.46K 2187
2019
Q2
$1K Sell
11
-6
-35% -$762 ﹤0.01% 2157
2019
Q1
$2K Sell
17
-6
-26% -$810 ﹤0.01% 2079
2018
Q4
$3K Hold
23
﹤0.01% 1862
2018
Q3
$4K Buy
+23
New +$3.87K ﹤0.01% 1481

Other funds holding ONC

Concourse Financial Group Securities's ONC Position: Q3 2024 in Review

Concourse Financial Group Securities sold out of BeOne Medicines Ltd (ONC) in Q3 2024, closing a stake of 3 shares — an estimated $540 sold.

Concourse Financial Group Securities first reported a position in ONC in Q3 2018 and held it in 21 quarters. The position peaked at $5K in Q3 2020. 228 funds tracked by Wall St. Rank hold ONC as of Q3 2024.

  • Concourse Financial Group Securities reported no remaining BeOne Medicines Ltd position as of Q3 2024 after selling out during the quarter.
  • Concourse Financial Group Securities sold 3 BeOne Medicines Ltd shares in Q3 2024, an estimated $540.
  • Concourse Financial Group Securities first reported a position in BeOne Medicines Ltd in Q3 2018 and held it in 21 quarters.
  • Concourse Financial Group Securities's BeOne Medicines Ltd position peaked at $5K in Q3 2020.
  • 228 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2024.

Based on Concourse Financial Group Securities's 13F filing for Q3 2024, filed 10 Oct 2024.